HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy

View/ Open
Issue date
2017-12-01Author
Mangraviti, Antonella
Raghavan, Tula
Volpin, Francesco
Skuli, Nicolas
Gullotti, David
Zhou, Jinyuan
Asnaghi, Laura
Sankey, Eric
Liu, Ann
Wang, Yuan
Lee, Dong-Hoon
Gorelick, Noah
Serra, Riccardo
Peters, Michael
Schriefer, Destiny
Rodriguez, Fausto J.
Eberhart, Charles G.
Brem, Henry
Olivi, Alessandro
Tyler, Betty
Suggested citation
Mangraviti, Antonella;
Raghavan, Tula;
Volpin, Francesco;
Skuli, Nicolas;
Gullotti, David;
Zhou, Jinyuan;
...
Tyler, Betty.
(2017)
.
HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.
Scientific Reports, 2017, vol. 7, núm. 14978.
https://doi.org/10.1038/s41598-017-14990-w.
Metadata
Show full item recordAbstract
Tumor progression, limited efficacy of current standard treatments, and the rise in patient mortality are associated with gene expression caused by the synergistic action of intratumoral hypoxia and HIF-1α activation. For this reason, recent investigations have focused on HIF-targeting therapeutic agents, with encouraging preclinical and clinical results in solid tumors. Here we describe the efficacy of a HIF-1α inhibitor, Acriflavine, and demonstrate its potency against brain cancer. This safe antibacterial dye induces cell death and apoptosis in several glioma cell lines, targets HIF-1α-mediated pathways, and decreases the level of PGK1, VEGF and HIF-1α in vitro and in vivo. Administered locally via biodegradable polymers, Acriflavine provides significant benefits in survival resulting in nearly 100% long term survival, confirmed by MRI and histological analyses. This study reports preclinical evidence that this safe, small molecule can contribute to brain tumor therapy and highlights the significance of HIF-1α-targeting molecules.
Is part of
Scientific Reports, 2017, vol. 7, núm. 14978European research projects
Collections
The following license files are associated with this item: